| Westover Retirement Community | |
| 855 Stahlheber Road, Hamilton, Ohio 45013 | |
| (513) 844-8004 | |
| Name | Westover Retirement Community |
|---|---|
| Location | 855 Stahlheber Road, Hamilton, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 53 |
| Occupancy Rate | 62.26% |
| Medicare ID (CCN) | 366232 |
| Legal Business Name | Colonial Senior Services, Inc. |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1275534265 |
| Organization Name | COLONIAL SENIOR SERVICES INC |
| Doing Business As | WESTOVER RETIREMENT COMMUNITY |
| Address | 855 Stahlheber Rd, 520 Eaton Ave, Hamilton, OH 45013 |
| Phone Number | 513-844-8004 |
News Archive
"The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue," write the authors of a Lancet Infectious Diseases review that examines what is known about the virus and progress in the development of a dengue vaccine (Webster et. al, 11/09).
Ministers have accepted the advice of the Committee on Safety of Medicines (CSM) that simvastatin 10mg (Zocor Heart Pro) could be safely sold through pharmacies to reduce the risk of a first major coronary event in people likely to be at a moderate risk of coronary heart disease (CHD).
Newsweek examines the genetic modification of mosquitoes in an effort to stem the spread of dengue fever and malaria. Dengue fever, which is transmitted by the Aedes Aegypti mosquito, "is spreading fast," according to the magazine, with more than 100 million people afflicted yearly. "There is no vaccine, no cure and no solution," it reports.
Sierra Sciences, in collaboration with TA Sciences, Geron Corporation, PhysioAge, and the Spanish National Cancer Research Center (CNIO), has announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
"The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue," write the authors of a Lancet Infectious Diseases review that examines what is known about the virus and progress in the development of a dengue vaccine (Webster et. al, 11/09).
Ministers have accepted the advice of the Committee on Safety of Medicines (CSM) that simvastatin 10mg (Zocor Heart Pro) could be safely sold through pharmacies to reduce the risk of a first major coronary event in people likely to be at a moderate risk of coronary heart disease (CHD).
Newsweek examines the genetic modification of mosquitoes in an effort to stem the spread of dengue fever and malaria. Dengue fever, which is transmitted by the Aedes Aegypti mosquito, "is spreading fast," according to the magazine, with more than 100 million people afflicted yearly. "There is no vaccine, no cure and no solution," it reports.
Sierra Sciences, in collaboration with TA Sciences, Geron Corporation, PhysioAge, and the Spanish National Cancer Research Center (CNIO), has announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.57 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 19.78 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 71.43 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.5 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.87 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.3 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.63 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.22 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.91 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.92 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.08 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 34.78 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.2 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.3 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 63.45 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.06 | 82.93 |
News Archive
"The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue," write the authors of a Lancet Infectious Diseases review that examines what is known about the virus and progress in the development of a dengue vaccine (Webster et. al, 11/09).
Ministers have accepted the advice of the Committee on Safety of Medicines (CSM) that simvastatin 10mg (Zocor Heart Pro) could be safely sold through pharmacies to reduce the risk of a first major coronary event in people likely to be at a moderate risk of coronary heart disease (CHD).
Newsweek examines the genetic modification of mosquitoes in an effort to stem the spread of dengue fever and malaria. Dengue fever, which is transmitted by the Aedes Aegypti mosquito, "is spreading fast," according to the magazine, with more than 100 million people afflicted yearly. "There is no vaccine, no cure and no solution," it reports.
Sierra Sciences, in collaboration with TA Sciences, Geron Corporation, PhysioAge, and the Spanish National Cancer Research Center (CNIO), has announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
› Verified 5 days ago
Diversicare Of Bradford Place Location: 1302 Millville Avenue, Hamilton, Ohio 45013 Phone: (513) 867-4101 | |
The Laurels Of Hamilton Location: 2923 Hamilton Mason Road, Hamilton, Ohio 45011 Phone: (513) 863-0360 | |
Berkeley Square Retirement Cen Location: 100 Berkeley Drive, Hamilton, Ohio 45013 Phone: (513) 856-8600 | |